FOLR1 and breast cancer: This spheroid disruption was not observed when the T lymphocytes activated by SmartDC-FRα was cocultured with FRα-negative MCF10A cells (Figure 6), which confirm the specific cytotoxicity against FRα-expressing BC cells of the SmartDC-FRα activated T lymphocytes.